Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

The initiative, focused on investigators from Memorial Sloan-Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Memorial Sloan-Kettering physicians and nurses take their knowledge and expertise overseas.

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan-Kettering is always in need of blood donations – especially during the holiday season.

Memorial Sloan-Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.